정밀 의료용 AI 시장 : 컴포넌트별, 치료 용도별, 기술별, 최종 용도별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 점유율 및 예측(2026-2033년)

AI in Precision Medicine Market size was valued at USD 1,056.3 Million in 2025, expanding to a CAGR of 29.7% from 2026 to 2033.

In precision medicine, AI means using smart data-processing systems and predictive analytics to analyze large amounts of patient-related data, including genomic data, clinical histories, diagnostic findings, and lifestyle characteristics. AI helps healthcare professionals to identify meaningful relationships in complex data sets and provide personalized approaches for disease prevention, diagnosis, and treatment. It improves the capability to predict patient outcomes, to identify health risks early and to optimize treatment decisions.

AI in Precision Medicine Market- Market Dynamics

Increasing integration of multi-omics data and advanced analytics and trend of personalized therapies are expected to propel market demand

AI in precision medicine market growth is accelerated by the rapid expansion of healthcare data and the increasing need to transform this information into actionable clinical insights. Hospitals, research institutions, and diagnostic laboratories generate enormous volumes of data from genomic sequencing, proteomic analysis, electronic health records, medical imaging systems, and connected health devices. AI technologies are playing a crucial role in organizing, analyzing, and interpreting these complex datasets, helping physicians make more precise and individualized treatment decisions. Recent advancements include AI-enabled genomic analysis platforms, large-scale healthcare foundation models and predictive algorithms proficient of identifying disease risks and therapy responses with more accuracy. According to industry reports, global healthcare data generation is growing by more than 30% per year, creating a solid demand for advanced analytical tools. In addition, healthcare organizations are increasingly implementing integrated data ecosystems that combine clinical, molecular, and real-world patient information into a unified framework. This development is improving disease prediction, supporting earlier interventions, and enabling more personalized care strategies. As the volume and complexity of healthcare data continue to rise, AI is becoming an indispensable component of next-generation precision medicine initiatives.

Another significant factor driving the AI in precision medicine market is the growing emphasis on personalized treatment approaches and the need to enhance efficiency across the drug development lifecycle. Pharmaceutical and biotechnology companies are increasingly leveraging AI to uncover new therapeutic targets, improve patient selection for clinical trials, and forecast treatment outcomes more accurately. These abilities help streamline research activities, lower development money, and increase the chances of successful product commercialization. Emerging developments include AI-powered biomarker identification, advanced patient segmentation techniques, and intelligent platforms that connect individuals with therapies best suitable for their genetic and clinical profiles. The rising adoption of precision oncology solutions, increasing focus on rare and genetic disorders and demand for customized management of chronic diseases are further accelerating market growth.

AI in Precision Medicine Market- Segmentation Analysis:

The Global AI in Precision Medicine Market is segmented on the basis of Component, Therapeutic Application, Technology, End-Use, and Region.

The market is divided into three categories based on Component: Hardware, software, and services. The software segment is leading the component segment due to the increasing adoption of AI-based solutions for genomic interpretation, predictive healthcare analytics, clinical decision support, and patient segmentation. In contrast, the hardware segment includes high-performance computing infrastructure, advanced data storage systems, and specialized AI processing units, which facilitate the efficient analysis of large-scale and complex medical datasets.

The market is divided into six categories based on Therapeutic Application: oncology, neurology, cardiology, infectious diseases, rare diseases, and others. Oncology holds the foremost share of the AI in precision medicine market due to the extensive adoption of AI technologies for early cancer detection, tumor profiling, biomarker discovery, treatment response prediction, and personalized therapy selection. AI-driven tools help clinicians analyze complex genomic and molecular data, enabling more accurate and targeted cancer treatment strategies. The increasing prevalence of cancer worldwide, coupled with rising investments in precision oncology research, continues to strengthen this segment's growth.

AI in Precision Medicine Market- Geographical Insights

North America leads the AI in precision medicine market, supported by its advanced healthcare infrastructure, strong biotechnology ecosystem, and extensive adoption of digital health technologies. The region benefits from large-scale genomic research initiatives, widespread use of electronic health records, and significant investments in artificial intelligence across healthcare applications. Pharmaceutical companies, research institutions, and healthcare providers are increasingly integrating AI into drug discovery, biomarker identification, and personalized treatment planning.

The increasing investments in healthcare digitalization, genomic medicine programs and AI-based clinical research make Europe a key market in AI precision medicine. Governments and healthcare organizations are supporting initiatives around personalized healthcare and data-driven disease management. The progressive adoption of AI tools for clinical decision support, population health analysis and precision oncology are aiding the growth of the market. One such initiative is 1+ Million Genomes Initiative, which promotes secure access to genomic and health-related data across participating European countries. This collaborative effort is accelerating genomic research, improving disease understanding, and strengthening the development of AI-powered precision medicine solutions throughout the region.

United States AI in Precision Medicine Market- Key Insights

The United States holds the largest share of the AI in precision medicine market due to its strong healthcare and biotechnology sectors, developed digital infrastructure and substantial investments in artificial intelligence research. The U.S. is home to various pharmaceutical companies, biotechnology firms, AI startups, and leading academic medical centers that are actively developing precision medicine solutions. The growing adoption of genomic sequencing, electronic health records, and AI-powered clinical decision support systems is accelerating market growth. Furthermore, rising investments in AI-driven drug discovery, biomarker identification, and predictive analytics are enabling faster and more precise treatment development. The availability of extensive healthcare datasets, favorable research funding, strong collaboration between technology and life sciences companies is also boosting U.S. position in the global market.

AI in Precision Medicine Market- Competitive Landscape:

The AI in Precision Medicine market is moderately competitive in nature. Market participants are focusing on integrating artificial intelligence with genomics, clinical data analytics, molecular diagnostics and drug discovery platforms to deliver more personalized healthcare solutions. A key trend shaping the competitive landscape is the development of end-to-end precision medicine ecosystems that combine patient data management, biomarker identification, predictive analytics and treatment optimization within a single platform.

Moreover, companies are progressively investing in advanced machine learning models, foundation AI models for healthcare, and multimodal analytics platforms capable of processing genomic, imaging, and clinical datasets simultaneously. Mergers, acquisitions, and technology partnerships are also helping organizations strengthen their product portfolios and expand their presence across global markets.

Recent Developments:

In February 2025, Tempus AI completed acquisition of Ambry Genetics, significantly expanding its precision medicine and molecular diagnostics portfolio. Through this transaction, the company gained access to a broader genomic database and advanced genetic testing capabilities, strengthening its AI-powered platform for disease detection.

In 2025, Illumina entered into a strategic collaboration with Tempus AI to integrate advanced genomic sequencing capabilities with AI-powered data analytics. The partnership aims to enhance molecular profiling, improve the interpretation of complex genomic data, and support the broader adoption of precision medicine.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL AI IN PRECISION MEDICINE MARKET KEY PLAYERS

• Tempus AI
• Illumina
• NVIDIA
• IBM
• Microsoft
• Google
• SOPHiA GENETICS
• IQVIA
• Guardant Health
• Astrazeneca
• Sanofi
• Roche
• Thermo Fisher Scientific
• Qiagen
• Bio-Rad Laboratories
• Others

GLOBAL AI IN PRECISION MEDICINE MARKET, BY COMPONENT- MARKET ANALYSIS, 2020-2033

• Hardware
• Software
• Services

GLOBAL AI IN PRECISION MEDICINE MARKET, BY THERAPEUTIC APPLICATION- MARKET ANALYSIS, 2020-2033

• Oncology
• Neurology
• Cardiology
• Infectious diseases
• Rare diseases
• Others

GLOBAL AI IN PRECISION MEDICINE MARKET, BY TECNOLOGY- MARKET ANALYSIS, 2020-2033

• Machine Learning (ML)
• Natural Language Processing (NLP)
• Computer Vision
• Others

GLOBAL AI IN PRECISION MEDICINE MARKET, BY END-USE- MARKET ANALYSIS, 2020-2033

• Drug Discovery & Development
• Genomic Analysis
• Precision Diagnostics
• Clinical Decision Support
• Predictive Analytics
• Others

GLOBAL AI IN PRECISION MEDICINE MARKET, BY REGION- MARKET ANALYSIS, 2020-2033

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. AI in Precision Medicine Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. AI in Precision Medicine Market Snippet by Component
  • 2.1.2. AI in Precision Medicine Market Snippet by Therapeutic Application
  • 2.1.3. AI in Precision Medicine Market Snippet by Technology
  • 2.1.4. AI in Precision Medicine Market Snippet by End-Use
  • 2.1.5. AI in Precision Medicine Market Snippet by Country
  • 2.1.6. AI in Precision Medicine Market Snippet by Region
• 2.2. Competitive Insights

3. AI in Precision Medicine Key Market Trends

• 3.1. AI in Precision Medicine Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. AI in Precision Medicine Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. AI in Precision Medicine Market Opportunities
• 3.4. AI in Precision Medicine Market Future Trends

4. AI in Precision Medicine Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. AI in Precision Medicine Market: Impact of Escalating Geopolitical Tensions

• 5.1. Impact of COVID-19 Pandemic
• 5.2. Impact of Russia-Ukraine War
• 5.3. Impact of Middle East Conflicts

6. AI in Precision Medicine Market Landscape

• 6.1. AI in Precision Medicine Market Share Analysis, 2025
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. AI in Precision Medicine Market - By Component

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Component, 2025 & 2033 (%)
  • 7.1.2. Hardware
  • 7.1.3. Software
  • 7.1.4. Services

8. AI in Precision Medicine Market - By Therapeutic Application

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Therapeutic Application, 2025 & 2033 (%)
  • 8.1.2. Oncology
  • 8.1.3. Neurology
  • 8.1.4. Cardiology
  • 8.1.5. Infectious diseases
  • 8.1.6. Rare diseases
  • 8.1.7. Others

9. AI in Precision Medicine Market - By Technology

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
  • 9.1.2. Machine Learning (ML)
  • 9.1.3. Natural Language Processing (NLP)
  • 9.1.4. Computer Vision
  • 9.1.5. Others

10. AI in Precision Medicine Market - By End-Use

• 10.1. Overview
  • 10.1.1. Segment Share Analysis, By End-Use, 2025 & 2033 (%)
  • 10.1.2. Drug Discovery & Development
  • 10.1.3. Genomic Analysis
  • 10.1.4. Precision Diagnostics
  • 10.1.5. Clinical Decision Support
  • 10.1.6. Predictive Analytics
  • 10.1.7. Others

11. AI in Precision Medicine Market- By Geography

• 11.1. Introduction
  • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
• 11.2. North America
  • 11.2.1. Overview
  • 11.2.2. AI in Precision Medicine Key Manufacturers in North America
  • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.2.4. North America Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  • 11.2.5. North America Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
  • 11.2.6. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.2.7. North America Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.2.8. U.S.
    • 11.2.8.1. Overview
    • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.2.8.3. U.S. Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.2.8.4. U.S. Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.2.8.5. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.2.8.6. U.S. Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.2.9. Canada
    • 11.2.9.1. Overview
    • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.2.9.3. Canada Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.2.9.4. Canada Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.2.9.5. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.2.9.6. Canada Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
• 11.3. Europe
  • 11.3.1. Overview
  • 11.3.2. AI in Precision Medicine Key Manufacturers in Europe
  • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.3.4. Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  • 11.3.5. Europe Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
  • 11.3.6. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.3.7. Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.3.8. Germany
    • 11.3.8.1. Overview
    • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.8.3. Germany Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.3.8.4. Germany Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.3.8.5. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.8.6. Germany Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.3.9. UK
    • 11.3.9.1. Overview
    • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.9.3. UK Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.3.9.4. UK Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.3.9.5. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.9.6. UK Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.3.10. France
    • 11.3.10.1. Overview
    • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.10.3. France Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.3.10.4. France Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.3.10.5. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.10.6. France Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.3.11. Italy
    • 11.3.11.1. Overview
    • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.11.3. Italy Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.3.11.4. Italy Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.3.11.5. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.11.6. Italy Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.3.12. Spain
    • 11.3.12.1. Overview
    • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.12.3. Spain Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.3.12.4. Spain Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.3.12.5. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.12.6. Spain Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.3.13. The Netherlands
    • 11.3.13.1. Overview
    • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.13.3. The Netherlands Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.3.13.4. The Netherlands Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.3.13.5. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.13.6. The Netherlands Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.3.14. Sweden
    • 11.3.14.1. Overview
    • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.14.3. Sweden Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.3.14.4. Sweden Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.3.14.5. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.14.6. Sweden Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.3.15. Russia
    • 11.3.15.1. Overview
    • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.15.3. Russia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.3.15.4. Russia Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.3.15.5. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.15.6. Russia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.3.16. Poland
    • 11.3.16.1. Overview
    • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.16.3. Poland Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.3.16.4. Poland Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.3.16.5. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.16.6. Poland Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.3.17. Rest of Europe
    • 11.3.17.1. Overview
    • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
• 11.4. Asia Pacific (APAC)
  • 11.4.1. Overview
  • 11.4.2. AI in Precision Medicine Key Manufacturers in Asia Pacific
  • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.4.4. APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  • 11.4.5. APAC Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
  • 11.4.6. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.4.7. APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.4.8. China
    • 11.4.8.1. Overview
    • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.8.3. China Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.4.8.4. China Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.4.8.5. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.8.6. China Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.4.9. India
    • 11.4.9.1. Overview
    • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.9.3. India Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.4.9.4. India Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.4.9.5. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.9.6. India Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.4.10. Japan
    • 11.4.10.1. Overview
    • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.10.3. Japan Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.4.10.4. Japan Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.4.10.5. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.10.6. Japan Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.4.11. South Korea
    • 11.4.11.1. Overview
    • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.11.3. South Korea Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.4.11.4. South Korea Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.4.11.5. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.11.6. South Korea Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.4.12. Australia
    • 11.4.12.1. Overview
    • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.12.3. Australia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.4.12.4. Australia Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.4.12.5. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.12.6. Australia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.4.13. Indonesia
    • 11.4.13.1. Overview
    • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.13.3. Indonesia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.4.13.4. Indonesia Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.4.13.5. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.13.6. Indonesia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.4.14. Thailand
    • 11.4.14.1. Overview
    • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.14.3. Thailand Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.4.14.4. Thailand Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.4.14.5. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.14.6. Thailand Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.4.15. Philippines
    • 11.4.15.1. Overview
    • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.15.3. Philippines Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.4.15.4. Philippines Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.4.15.5. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.15.6. Philippines Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.4.16. Rest of APAC
    • 11.4.16.1. Overview
    • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.16.3. Rest of APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.4.16.4. Rest of APAC Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.4.16.5. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
• 11.5. Latin America (LATAM)
  • 11.5.1. Overview
  • 11.5.2. AI in Precision Medicine Key Manufacturers in Latin America
  • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.5.4. LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  • 11.5.5. LATAM Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
  • 11.5.6. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.5.7. LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.5.8. Brazil
    • 11.5.8.1. Overview
    • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.8.3. Brazil Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.5.8.4. Brazil Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.5.8.5. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.8.6. Brazil Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.5.9. Mexico
    • 11.5.9.1. Overview
    • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.9.3. Mexico Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.5.9.4. Mexico Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.5.9.5. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.9.6. Mexico Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.5.10. Argentina
    • 11.5.10.1. Overview
    • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.10.3. Argentina Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.5.10.4. Argentina Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.5.10.5. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.10.6. Argentina Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.5.11. Colombia
    • 11.5.11.1. Overview
    • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.11.3. Colombia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.5.11.4. Colombia Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.5.11.5. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.11.6. Colombia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.5.12. Rest of LATAM
    • 11.5.12.1. Overview
    • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
• 11.6. Middle East and Africa (MEA)
  • 11.6.1. Overview
  • 11.6.2. AI in Precision Medicine Key Manufacturers in Middle East and Africa
  • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.6.4. MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  • 11.6.5. MEA Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
  • 11.6.6. MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.6.7. MEA Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.6.8. Saudi Arabia
    • 11.6.8.1. Overview
    • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.6.9. United Arab Emirates
    • 11.6.9.1. Overview
    • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.6.10. Israel
    • 11.6.10.1. Overview
    • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.10.3. Israel Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.6.10.4. Israel Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.6.10.5. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.10.6. Israel Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.6.11. Turkey
    • 11.6.11.1. Overview
    • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.11.3. Turkey Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.6.11.4. Turkey Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.6.11.5. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.11.6. Turkey Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.6.12. Algeria
    • 11.6.12.1. Overview
    • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.12.3. Algeria Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.6.12.4. Algeria Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.6.12.5. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.12.6. Algeria Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.6.13. Egypt
    • 11.6.13.1. Overview
    • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.13.3. Egypt Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.6.13.4. Egypt Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.6.13.5. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.13.6. Egypt Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.6.14. Rest of MEA
    • 11.6.14.1. Overview
    • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.14.3. Rest of MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.6.14.4. Rest of MEA Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.6.14.5. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- AI in Precision Medicine Industry

• 12.1. Competitive Dashboard
  • 12.1.1. Competitive Benchmarking
  • 12.1.2. Competitive Positioning
• 12.2. Company Profiles
  • 12.2.1. Tempus AI
  • 12.2.2. Illumina
  • 12.2.3. NVIDIA
  • 12.2.4. IBM
  • 12.2.5. Microsoft
  • 12.2.6. Google
  • 12.2.7. SOPHiA GENETICS
  • 12.2.8. IQVIA
  • 12.2.9. Guardant Health
  • 12.2.10. Astrazeneca
  • 12.2.11. Sanofi
  • 12.2.12. Roche
  • 12.2.13. Thermo Fisher Scientific
  • 12.2.14. Qiagen
  • 12.2.15. Bio-Rad Laboratories
  • 12.2.16. Others

13. 360 Degree AnalystView

14. Appendix

• 14.1. Research Methodology
• 14.2. References
• 14.3. Abbreviations
• 14.4. Disclaimer
• 14.5. Contact Us